Funder: National Institutes of Health
Due Dates: June 1, 2026 (Forecasted)
Funding Amounts: Not specified; award ceiling/floor not listed.
Summary: Enables partnered research using All of Us Biobank biospecimens to advance biomarker analysis and precision medicine.
Key Information: Forecasted opportunity; details (including funding) may change.